Phase III Stem Cell Trial for Epilepsy Launching This Year from Neurona Therapeutics
This follows their RMAT designation, and promising Phase 1/2 trial results, which they presented earlier this year.
Neurology
FDA approves new nerve repair product from Orthocell
With FDA approval now secured, Orthocell prepares to launch Remplir into the lucrative US nerve repair market, accelerating commercialisation.
Chinese stem cell (iPSC) therapies receive Phase I trial clearance for ALS & Parkinson’s
They'll be using allogeneic iPSCs to treat neurodegenerative disorders. ALS stem cells can be a tough topic after the Nurown trials... are iPSCs the answer?
Brain cancer stem cell trial begins recruitment: Calidi Biotherapeutics ships first batch to Northwestern University for the trial
The trial leverages Calidi’s innovative virotherapy platform, offering new hope for combating this aggressive form of brain cancer.
BrainStorm Cell Therapeutics Gearing Up for Phase 3b Trial of NurOwn, Its ALS Stem Cell Therapy, Submits IND Amendment
The amended IND application moves NurOwn® closer to initiation of the pivotal Phase 3b clinical trial for ALS patients.
Joseph Spine Institute Launches Adipose Stem Cell Spine Institute in Florida
Joseph Spine Institute launches its Center for Regenerative Spine Medicine in Tampa, offering minimally invasive stem cell therapies for chronic spinal conditions.
Cellino and Matricelf Partnering to Scale Stem Cells for Spinal Cord Injury
Cellino has successfully manufactured and delivered patient-specific autologous induced pluripotent stem cell (iPSC) lines from four donors to Matricelf for spinal cord injury treatment.
Wharton’s Jelly-Derived Mesenchymal Stem Cells Shows Promise for Traumatic Brain Injury: Results from Phase I Study (2024)
Traumatic brain injury (TBI) occurs when trauma disrupts normal brain functions, potentially causing severe physical, cognitive, and emotional impairments. Researchers are exploring stem cells as a possible treatment because these cells might...
NASA awards $3.1M grant to continue studying stem cells aboard International Space Station
The National Stem Cell Foundation (NSCF) has received a $3.1 million grant from NASA to further its research on neurodegenerative diseases aboard the International Space Station (ISS). This funding will support additional...
MIT engineers turn skin cells directly into neurons for cell therapy
MIT researchers have developed a new method to convert skin cells directly into neurons, bypassing the pluripotent stem cell stage in iPSC development. This technique, demonstrated in mouse cells, could potentially lead...